Incidence, Patterns and Predictors of Alemtuzumab-Induced Thyroid Dysfunction in Patients With Multiple Sclerosis: A Northern Ireland Cohort Study.

Flynn DO, Kennedy F, Hughes S, Magill F, Mc Donnell GV, Black N, Darrat M, Mullan G, Darcy R, McCance DR, Spence K, Johnston PC

Open source

DOI
10.1111/cen.70201
Published
2026 Aug 13
Container
Clinical endocrinology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cen.70201,
  title = {Incidence, Patterns and Predictors of Alemtuzumab-Induced Thyroid Dysfunction in Patients With Multiple Sclerosis: A Northern Ireland Cohort Study.},
  author = {Flynn DO and Kennedy F and Hughes S and Magill F and Mc Donnell GV and Black N and Darrat M and Mullan G and Darcy R and McCance DR and Spence K and Johnston PC},
  year = {2026},
  journal = {Clinical endocrinology},
  doi = {10.1111/cen.70201},
  url = {https://doi.org/10.1111/cen.70201}
}

RIS

TY  - JOUR
TI  - Incidence, Patterns and Predictors of Alemtuzumab-Induced Thyroid Dysfunction in Patients With Multiple Sclerosis: A Northern Ireland Cohort Study.
AU  - Flynn DO
AU  - Kennedy F
AU  - Hughes S
AU  - Magill F
AU  - Mc Donnell GV
AU  - Black N
AU  - Darrat M
AU  - Mullan G
AU  - Darcy R
AU  - McCance DR
AU  - Spence K
AU  - Johnston PC
PY  - 2026
JO  - Clinical endocrinology
DO  - 10.1111/cen.70201
UR  - https://doi.org/10.1111/cen.70201
ER  - 

APA

DO, F., F, K., S, H., F, M., GV, M. D., N, B., M, D., G, M., R, D., DR, M., K, S., & PC, J. (2026). Incidence, Patterns and Predictors of Alemtuzumab-Induced Thyroid Dysfunction in Patients With Multiple Sclerosis: A Northern Ireland Cohort Study.. Clinical endocrinology. https://doi.org/10.1111/cen.70201

Source records